Citigroup 6.875% Series K Preferred Stock
C.PRK
C.PRK was delisted on the 14th of November, 2023.
3 hedge funds and large institutions have $38.4K invested in Citigroup 6.875% Series K Preferred Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less capital inflows, than outflows
Capital inflows: $8.48K | Capital outflows: $4.64M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$8.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Connectus Wealth
Cincinnati,
Ohio
|
-$4.64M |
C.PRK Hedge Fund Activity: Q4 2022 in Review
3 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Citigroup 6.875% Series K Preferred Stock (C.PRK) for Q4 2022, worth a combined $38.4K — down 99% from $5.78M a quarter earlier.
Fund positioning in C.PRK was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was PNC Financial Services Group, opening a new position worth an estimated $8.48K. The largest seller was Connectus Wealth, exiting entirely with an estimated $4.64M sold.
- 3 institutional investors held Citigroup 6.875% Series K Preferred Stock (C.PRK) as of Q4 2022, down from 4 in Q3 2022.
- Funds reported $38.4K of Citigroup 6.875% Series K Preferred Stock stock for Q4 2022, down 99% quarter-over-quarter.
- 1 fund opened new Citigroup 6.875% Series K Preferred Stock positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest Citigroup 6.875% Series K Preferred Stock buyer in Q4 2022 was PNC Financial Services Group, an estimated $8.48K added.
- The largest Citigroup 6.875% Series K Preferred Stock seller in Q4 2022 was Connectus Wealth, an estimated $4.64M sold.
Based on aggregated 13F filings for Q4 2022.